PT900563E - Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas - Google Patents

Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas

Info

Publication number
PT900563E
PT900563E PT98116194T PT98116194T PT900563E PT 900563 E PT900563 E PT 900563E PT 98116194 T PT98116194 T PT 98116194T PT 98116194 T PT98116194 T PT 98116194T PT 900563 E PT900563 E PT 900563E
Authority
PT
Portugal
Prior art keywords
edema
treatment
production
pharmaceutical formulations
venous diseases
Prior art date
Application number
PT98116194T
Other languages
English (en)
Inventor
James Tobin
Gerd Ulfert Heese
Original Assignee
Klinge Co Chem Pharm Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Co Chem Pharm Fab filed Critical Klinge Co Chem Pharm Fab
Publication of PT900563E publication Critical patent/PT900563E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
PT98116194T 1997-09-02 1998-08-27 Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas PT900563E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/921,694 US6077534A (en) 1997-09-02 1997-09-02 Production of pharmaceutical formulations for treatment of edema and venous disorders

Publications (1)

Publication Number Publication Date
PT900563E true PT900563E (pt) 2004-06-30

Family

ID=25445835

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98116194T PT900563E (pt) 1997-09-02 1998-08-27 Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas

Country Status (5)

Country Link
US (1) US6077534A (pt)
EP (1) EP0900563B1 (pt)
CA (1) CA2245370C (pt)
ES (1) ES2216219T3 (pt)
PT (1) PT900563E (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10012569A1 (de) * 2000-03-15 2001-09-20 Finzelberg Gmbh & Co Kg Hartgelatinekapseln enthaltend retardierte Pflanzenextrakte und Verfahren zur Herstellung derselben
DE10122715A1 (de) * 2001-05-10 2002-11-21 Brench Ag Verwendung von Rutinen und Aescinen zur Behandlung aurikulärer Durchblutungsstörungen
DE10122714A1 (de) * 2001-05-10 2002-11-21 Brench Ag Verwendung von Rutinen und Aescinen zur Behandlung okulärer Durchblutungsstörungen
EP1438059A4 (en) * 2001-10-26 2008-01-23 Angiolab Inc COMPOSITION CONTAINING EXTRACT OF BROWN FROM INDIA PREPARED FOR ANTI-ANGIOGENIC ACTIVITY AND INHIBITOR OF MATRIX METALLOPROTEINASE
KR100533777B1 (ko) * 2001-10-26 2005-12-06 주식회사 안지오랩 칠엽수 추출물을 유효성분으로 하는 혈관신생 억제용 조성물
PL193976B1 (pl) * 2002-07-01 2007-04-30 Pliva Krakow Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid
EP1811839A4 (en) * 2004-11-18 2008-08-06 Univ Rochester METHOD AND COMPOSITIONS IN CONNECTION WITH ESCULENTOSIDE A
KR100882265B1 (ko) * 2007-01-29 2009-02-09 주식회사 안지오랩 칠엽수잎 추출물의 제조방법
US20080292680A1 (en) * 2007-05-14 2008-11-27 Sustained Nano Systems Llc Hypercompressed polymer particles for controlled release ophthalmic medications
US8071119B2 (en) * 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
US20090148498A1 (en) * 2007-05-14 2009-06-11 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
CA2854054C (en) * 2011-12-02 2020-05-12 Pegasus Laboratories, Inc. Amphipathic lipid-based sustained release compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH283585A (de) * 1950-03-15 1952-06-15 Hoffmann La Roche Zur Herstellung von Tablettenüberzügen geeignetes Gemisch.
US3139383A (en) * 1961-06-26 1964-06-30 Norton Co Encapsulated time release pellets and method for encapsulating the same
US3450691A (en) * 1967-06-07 1969-06-17 Klinge Co Chem Pharm Fab Process of producing a water soluble horse chestnut saponin of low hemolytic activity and product
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
DE3643000A1 (de) * 1986-12-17 1988-06-30 Carolus Apotheke Dr Norma Beck Kombinationspraeparate aus schleifendiuretika und die renale durchblutung foerdernden phytopharmaka
HU202743B (en) * 1988-06-24 1991-04-29 Richter Gedeon Vegyeszet Active ingredient composition comprising medicinal herb extracts, cosmetics comprising such active ingredient and process for producing medicinal and veterinary compositions
US5578307A (en) * 1992-01-17 1996-11-26 Alfatec-Pharma Gmbh Shaped articles containing plant extract(s), in particular pellets, and their pharmaceutical or cosmetic use
DE19629040A1 (de) * 1996-07-19 1998-01-22 Basf Ag Pflanzenextrakthaltige Arzneiformen

Also Published As

Publication number Publication date
CA2245370C (en) 2009-07-28
ES2216219T3 (es) 2004-10-16
EP0900563B1 (en) 2004-02-11
EP0900563A1 (en) 1999-03-10
US6077534A (en) 2000-06-20
CA2245370A1 (en) 1999-03-02

Similar Documents

Publication Publication Date Title
PT966436E (pt) Arilsulfonamidas e analogos e sua aplicacao para o tratamento de doencas neurodegenerativas
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
IS5500A (is) Lyfjablöndur til öftrunar og meðferðar mýlildi ogtengdum sjúkdómum
EE04156B1 (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
EE200300214A (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
CY2014005I2 (el) Τοπικα συστηματα παροχης γελης για την θεραπευτικη αντιμετωπιση των διαταραχων δερματος
DK0730864T3 (da) Lægemiddel til behandling af inflammatoriske hjertesygdomme
PT977748E (pt) Derivados benzopirano substituidos para o tratamento de inflamacao
PT900563E (pt) Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
PT1041985E (pt) Combinacao de compostos benzociclo-heptapiridina e farmacos antineoplasicos para tratar doencas proliferativas
ID27576A (id) Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
PT983275E (pt) Novos derivados do triptolido vantajosos para o tratamento de doencas autoimunes
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
NO995231D0 (no) Terapeutisk behandling av hudlidelser
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
NO991164D0 (no) Farmas°ytisk preparat for behandling av virussykdommer
EE9700235A (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
PT1225890E (pt) Rivastigmina para o tratamento de doencas oculares
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
BR9608595A (pt) Utilização de n-cicloexil benzamidas para o tratamento de aglições intestinais
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
DE69840432D1 (de) Arzneimittel zur behandlung der augen
EE200200698A (et) Ravimid neurodegeneratiivsete haiguste ennetamiseks ja raviks